Daiken Biomedical Co Ltd
TWSE:7780
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Daiken Biomedical Co Ltd
TWSE:7780
|
TW |
|
Innovative Eyewear Inc
NASDAQ:LUCY
|
US |
|
E
|
EuroTeleSites AG
VSE:ETS
|
AT |
|
C
|
Cartesian Growth Corp III
NASDAQ:CGCT
|
US |
|
S
|
Stark Corporation PCL
SET:STARK
|
TH |
|
E
|
Element Nutritional Sciences Inc
CNSX:ELMT
|
CA |
|
S
|
Suncliff Inc
OTC:SCLF
|
US |
|
H
|
Hans Biomed Corp
KOSDAQ:042520
|
KR |
|
A
|
Astro Resources NL
ASX:ARO
|
AU |
|
C
|
Centor Energy Inc
OTC:CNTO
|
US |
|
D
|
DGO Gold Ltd
F:48D
|
AU |
|
N
|
Nordic Technology Group AS
F:UA5
|
NO |
|
St-Georges Eco-Mining Corp
F:85G1
|
CA |
|
T
|
Taishin Financial Holding Co Ltd
TWSE:2887E
|
TW |
Dividends
Dividend Yield
Daiken Biomedical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Daiken Biomedical Co Ltd
Payout Ratio
Daiken Biomedical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Daiken Biomedical Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Daiken Biomedical Co Ltd
| Average Annual Return | 1.41% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -54% |
| Market Capitalization | 13.6B TWD |
| Shares Outstanding | 810 020 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Daiken Biomedical Co Ltd's latest stock split occurred on Jan 9, 2026
The company executed a 10-for-1 stock split, meaning that for every share held, investors received 10 new shares.
Before the split, Daiken Biomedical Co Ltd traded at 18.5 per share. Afterward, the share price was about 18.5.
The adjusted shares began trading on Jan 9, 2026. This was the only stock split in Daiken Biomedical Co Ltd's history.
